![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61K 39/395 | (2006.01) |
A61K 47/18 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
C07K 16/28 | (2006.01) |
(11) | Number of the document | 1865986 |
(13) | Kind of document | T |
(96) | European patent application number | 06736812.6 |
Date of filing the European patent application | 2006-03-02 | |
(97) | Date of publication of the European application | 2007-12-19 |
(45) | Date of publication and mention of the grant of the patent | 2016-02-17 |
(46) | Date of publication of the claims translation | 2016-06-10 |
(86) | Number | PCT/US2006/007555 |
Date | 2006-03-02 |
(87) | Number | WO 2006/096491 |
Date | 2006-09-14 |
(30) | Number | Date | Country code |
659766 P | 2005-03-08 | US | |
728165 P | 2005-10-19 | US | |
752712 P | 2005-12-20 | US | |
762456 P | 2006-01-26 | US |
(72) |
ABATE, Justin Donald, US
DAS, Tapan Kanti, US
ELLIOTT, Carrie Marie, US
MUTHURANIA, Kevin Wamiti, US
NEMA, Sandeep, US
SINGH, Satish Kumar, US
|
(73) |
Pfizer Products Inc.,
Eastern Point Road, Groton, CT 06340,
US
|
(74) |
Tatjana STERLINA,
UAB "Intels", Naugarduko g. 32/2, LT-03225 Vilnius,
LT
|
(54) | Anti-CTLA-4 antikūnų kompozicijos |
ANTI-CTLA-4 ANTIBODY COMPOSITIONS |
Payment date | Validity (years) | Amount | |
2017-02-27 | 12 | 289.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2018-03-02 |